Pharmacokinetics and safety of LY334370, a novel oral 5-HT1F selective agonist, in patients during migraine.

Granier, LA; De Suray, JM; Pereira, A

Pharmacokinetics and safety of LY334370, a novel oral 5-HT1F selective agonist, in patients during migraine.

Granier, LA

;

De Suray, JM

;

Pereira, A

(1999)

Files

No attached file found for this publication.

Details

Authors

Granier, LA
Author
De Suray, JM
Author
Pereira, A
Author

Affiliations

UCLouvain

Citations

APA
Chicago
FWB

Granier, L., De Suray, J., & Pereira, A. (1999). Pharmacokinetics and safety of LY334370, a novel oral 5-HT1F selective agonist, in patients during migraine. Clinical Pharmacology and Therapeutics, 65(2), 129. (Original work published 1999)